Dr. Robert Levin, MD
Claim this profileClinical Research of West Florida, Inc. (Clearwater)
Studies Arthritis
Studies Systemic Lupus Erythematosus
20 reported clinical trials
28 drugs studied
Affiliated Hospitals
Clinical Trials Robert Levin, MD is currently running
Litifilimab
for Lupus
In this study, researchers will learn more about a study drug called litifilimab (BIIB059) in participants with systemic lupus erythematosus (SLE). The study will focus on participants who have active disease and are already taking standard of care medications. These may include antimalarials, steroids, and immunosuppressants. The main objective of the study is to learn about the effect litifilimab has on lowering the activity of the disease. The main question researchers want to answer is: - How many participants have an improvement in their symptoms after 52 weeks of treatment? Researchers will answer this and other questions by measuring the symptoms of SLE over time using a variety of scoring tools. These include the SLE Responder Index (SRI), the Systemic Lupus Erythematosus Disease Activity Index-2000 (SLEDAI-2K), and the Patient Global Assessment - Visual Analog Scale (PGA-VAS). Researchers will also learn more about the safety of litifilimab. They will study how participants' immune systems respond to litifilimab. Additionally, they will measure the effect litifilimab and SLE have on the quality of life of participants using a group of questionnaires. The study will be done as follows: * After screening, participants will be randomized to receive either a high or low dose of litifilimab, or placebo. A placebo looks like the study drug but contains no real medicine. * All participants will receive either litifilimab or placebo as injections under the skin once every 4 weeks. The treatment period will last 52 weeks. Participants will continue to take their standard of care medications. * Neither the researchers nor the participants will know if the participants are receiving litifilimab or placebo. * There will be a follow-up safety period that lasts up to 24 weeks. * In total, participants will have up to 22 study visits. The total study duration for participants will be up to 80 weeks.
Recruiting1 award Phase 3
Non-TNFi Biologics vs Targeted Synthetic DMARDs
for Rheumatoid Arthritis
This trial is testing advanced medications for RA patients who haven't responded to standard treatments. It compares biologic drugs that target immune proteins and synthetic drugs that block harmful molecules in immune cells. The goal is to see which treatment improves patients' quality of life and daily functioning better. Biologic therapies have notably improved the treatment of RA, making disease remission a realistic goal.
Recruiting2 awards Phase 34 criteria
More about Robert Levin, MD
Clinical Trial Related3 years of experience running clinical trials · Led 20 trials as a Principal Investigator · 10 Active Clinical TrialsTreatments Robert Levin, MD has experience with
- Placebo
- Tildrakizumab
- Ianalumab
- Deucravacitinib
- Vectra DA
- Usual Care
Breakdown of trials Robert Levin, MD has run
Arthritis
Systemic Lupus Erythematosus
Rheumatoid Arthritis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Robert Levin, MD specialize in?
Robert Levin, MD focuses on Arthritis and Systemic Lupus Erythematosus. In particular, much of their work with Arthritis has involved treating patients, or patients who are undergoing treatment.
Is Robert Levin, MD currently recruiting for clinical trials?
Yes, Robert Levin, MD is currently recruiting for 10 clinical trials in Clearwater Florida. If you're interested in participating, you should apply.
Are there any treatments that Robert Levin, MD has studied deeply?
Yes, Robert Levin, MD has studied treatments such as Placebo, Tildrakizumab, Ianalumab.
What is the best way to schedule an appointment with Robert Levin, MD?
Apply for one of the trials that Robert Levin, MD is conducting.
What is the office address of Robert Levin, MD?
The office of Robert Levin, MD is located at: Clinical Research of West Florida, Inc. (Clearwater), Clearwater, Florida 33765 United States. This is the address for their practice at the Clinical Research of West Florida, Inc. (Clearwater).
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.